Paul McBarron
2019
In 2019, Paul McBarron earned a total compensation of $542.3K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary at Cyclacel Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Bonus | $82,615 |
|---|---|
| Option Awards | $164,198 |
| Salary | $275,381 |
| Other | $20,096 |
| Total | $542,290 |
McBarron received $275.4K in salary, accounting for 51% of the total pay in 2019.
McBarron also received $82.6K in bonus, $164.2K in option awards and $20.1K in other compensation.
Rankings
In 2019, Paul McBarron's compensation ranked 11,514th out of 13,971 executives tracked by ExecPay. In other words, McBarron earned more than 17.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,514 out of 13,971 | 18th |
Division Manufacturing | 4,665 out of 5,698 | 18th |
Major group Chemicals And Allied Products | 1,838 out of 2,197 | 16th |
Industry group Drugs | 1,582 out of 1,883 | 16th |
Industry Pharmaceutical Preparations | 1,170 out of 1,395 | 16th |
Source: SEC filing on May 12, 2020.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2019.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020